News
First Subject Dosed in CANbridge Pharma CAN106 rare disease trial in Singapore for PNH and complement dysregulation diseases Contacts CANbridge Pharmaceuticals Inc. [email protected] ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback